2. QUALITATIVE AND QUANTITATIVE …
Internal document code 4 Cyc11 0418iNZ hyperaemia, conjunctivitis, blepharoconjunctivitis, punctate keratitis, synechiae. Systemic Use of cyclopentolate has been associated with psychotic reactions and behavioural
Download 2. QUALITATIVE AND QUANTITATIVE …
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
ICD-10-CM Coding for Mental and Behavioral …
static.aapc.com9/13/2013 3 ICD-10-CM Coding for Mental and Behavioral Disorders Use, abuse, and dependence •Codes located in categories F10-F19 •3rd character indicates substance used •4th and 5th characters indicate the psychopathological syndrome
Hallucinations in children: Diagnostic and …
www.julianjaynes.orgCurrent Psychiatry 54 October 2010 Hallucinations in children Visit this article at CurrentPsychiatry.com for a bibliography of childhood hallucinations literature
Antenex - Medicines
www.medicines.org.auAntenex – Product Information 4 . Amnesia . Transient amnesia or memory impairment has been reported in association with the use of benzodiazepines.
PSYCHOTROPIC MEDICATION LIST ABOUT THIS …
www.ohiomindsmatter.orgPsychotropic Medication List Page 1 PSYCHOTROPIC MEDICATION LIST ABOUT THIS LIST DOSING This list presents psychotropic medications, recommended starting and maximum dosages, FDA approved indications,
The ICD-10 Classification of Mental and Behavioural ...
www.who.int1 World Health Organization F10 - F19 Mental and behavioural disorders due to psychoactive substance use Overview of this block F10. – Mental and behavioural disorders due to use of alcohol